179 related articles for article (PubMed ID: 15538748)
1. Identification of hypoxia-inducible factor-1alpha (HIF-1alpha) polymorphism as a mutation in prostate cancer that prevents normoxia-induced degradation.
Fu XS; Choi E; Bubley GJ; Balk SP
Prostate; 2005 May; 63(3):215-21. PubMed ID: 15538748
[TBL] [Abstract][Full Text] [Related]
2. Human hormone-refractory prostate cancers can harbor mutations in the O(2)-dependent degradation domain of hypoxia inducible factor-1alpha (HIF-1alpha).
Anastasiadis AG; Ghafar MA; Salomon L; Vacherot F; Benedit P; Chen MW; Shabsigh A; Burchardt M; Chopin DK; Shabsigh R; Buttyan R
J Cancer Res Clin Oncol; 2002 Jul; 128(7):358-62. PubMed ID: 12136249
[TBL] [Abstract][Full Text] [Related]
3. The homozygous P582S mutation in the oxygen-dependent degradation domain of HIF-1 alpha is associated with increased risk for prostate cancer.
Orr-Urtreger A; Bar-Shira A; Matzkin H; Mabjeesh NJ
Prostate; 2007 Jan; 67(1):8-13. PubMed ID: 16998808
[TBL] [Abstract][Full Text] [Related]
4. Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch.
Lando D; Peet DJ; Whelan DA; Gorman JJ; Whitelaw ML
Science; 2002 Feb; 295(5556):858-61. PubMed ID: 11823643
[TBL] [Abstract][Full Text] [Related]
5. Mutation analysis of the HIF-1alpha oxygen-dependent degradation domain in invasive breast cancer.
Vleugel MM; Greijer AE; van der Wall E; van Diest PJ
Cancer Genet Cytogenet; 2005 Dec; 163(2):168-72. PubMed ID: 16337862
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of hypoxia inducible factor-1alpha in rat and human prostate cancer.
Zhong H; Agani F; Baccala AA; Laughner E; Rioseco-Camacho N; Isaacs WB; Simons JW; Semenza GL
Cancer Res; 1998 Dec; 58(23):5280-4. PubMed ID: 9850048
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-inducible factor-1 in human breast and prostate cancer.
Kimbro KS; Simons JW
Endocr Relat Cancer; 2006 Sep; 13(3):739-49. PubMed ID: 16954428
[TBL] [Abstract][Full Text] [Related]
8. Identification of thioredoxin-interacting protein 1 as a hypoxia-inducible factor 1alpha-induced gene in pancreatic cancer.
Baker AF; Koh MY; Williams RR; James B; Wang H; Tate WR; Gallegos A; Von Hoff DD; Han H; Powis G
Pancreas; 2008 Mar; 36(2):178-86. PubMed ID: 18376310
[TBL] [Abstract][Full Text] [Related]
9. Resistance to caspase-dependent, hypoxia-induced apoptosis is not hypoxia-inducible factor-1 alpha mediated in prostate carcinoma cells.
Coffey RN; Morrissey C; Taylor CT; Fitzpatrick JM; Watson RW
Cancer; 2005 Apr; 103(7):1363-74. PubMed ID: 15719438
[TBL] [Abstract][Full Text] [Related]
10. Association between ulcerative growth and hypoxia inducible factor-1alpha polymorphisms in colorectal cancer patients.
Fransén K; Fenech M; Fredrikson M; Dabrosin C; Söderkvist P
Mol Carcinog; 2006 Nov; 45(11):833-40. PubMed ID: 16865676
[TBL] [Abstract][Full Text] [Related]
11. Coordinate regulation of the oxygen-dependent degradation domains of hypoxia-inducible factor 1 alpha.
Chan DA; Sutphin PD; Yen SE; Giaccia AJ
Mol Cell Biol; 2005 Aug; 25(15):6415-26. PubMed ID: 16024780
[TBL] [Abstract][Full Text] [Related]
12. Epigallocatechin gallate inhibits HIF-1alpha degradation in prostate cancer cells.
Thomas R; Kim MH
Biochem Biophys Res Commun; 2005 Aug; 334(2):543-8. PubMed ID: 16005427
[TBL] [Abstract][Full Text] [Related]
13. 6-Mercaptopurine, an activator of Nur77, enhances transcriptional activity of HIF-1alpha resulting in new vessel formation.
Yoo YG; Na TY; Yang WK; Kim HJ; Lee IK; Kong G; Chung JH; Lee MO
Oncogene; 2007 May; 26(26):3823-34. PubMed ID: 17146432
[TBL] [Abstract][Full Text] [Related]
14. Normoxic stabilization of hypoxia-inducible factor-1alpha by modulation of the labile iron pool in differentiating U937 macrophages: effect of natural resistance-associated macrophage protein 1.
Knowles HJ; Mole DR; Ratcliffe PJ; Harris AL
Cancer Res; 2006 Mar; 66(5):2600-7. PubMed ID: 16510578
[TBL] [Abstract][Full Text] [Related]
15. [Mechanism of recombinant adenovirus-mediated mutations of hypoxia inducible factor 1alpha in modulation of cell apoptosis].
Wei LL; Wu PS; Wang YG; Hu YF; Xie YJ
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):309-12. PubMed ID: 18359679
[TBL] [Abstract][Full Text] [Related]
16. Effects of geldanamycin on HIF-1alpha mediated angiogenesis and invasion in prostate cancer cells.
Alqawi O; Moghaddas M; Singh G
Prostate Cancer Prostatic Dis; 2006; 9(2):126-35. PubMed ID: 16432534
[TBL] [Abstract][Full Text] [Related]
17. Reactive oxygen species stabilize hypoxia-inducible factor-1 alpha protein and stimulate transcriptional activity via AMP-activated protein kinase in DU145 human prostate cancer cells.
Jung SN; Yang WK; Kim J; Kim HS; Kim EJ; Yun H; Park H; Kim SS; Choe W; Kang I; Ha J
Carcinogenesis; 2008 Apr; 29(4):713-21. PubMed ID: 18258605
[TBL] [Abstract][Full Text] [Related]
18. The C1772T genetic polymorphism in human HIF-1alpha gene associates with expression of HIF-1alpha protein in breast cancer.
Kim HO; Jo YH; Lee J; Lee SS; Yoon KS
Oncol Rep; 2008 Nov; 20(5):1181-7. PubMed ID: 18949419
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel small molecule inhibitors of hypoxia-inducible factor-1 that differentially block hypoxia-inducible factor-1 activity and hypoxia-inducible factor-1alpha induction in response to hypoxic stress and growth factors.
Chau NM; Rogers P; Aherne W; Carroll V; Collins I; McDonald E; Workman P; Ashcroft M
Cancer Res; 2005 Jun; 65(11):4918-28. PubMed ID: 15930314
[TBL] [Abstract][Full Text] [Related]
20. Reactive oxygen species attenuate nitric-oxide-mediated hypoxia-inducible factor-1alpha stabilization.
Köhl R; Zhou J; Brüne B
Free Radic Biol Med; 2006 Apr; 40(8):1430-42. PubMed ID: 16631533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
